Amgen (AMGN) Construction in Progress (2009 - 2022)

Amgen has reported Construction in Progress for 14 years, with the latest figure at $1.2 billion in Q4 2022.

• On a quarterly basis, Construction in Progress rose 22.9% year-over-year to $1.2 billion in Q4 2022; TTM through Dec 2022 was $1.2 billion, a 22.9% increase from a year earlier, with the FY2022 full-year figure at $1.2 billion, up 22.9% from the prior year.
• Construction in Progress was $1.2 billion for Q4 2022 at Amgen, up from $987.0 million in the prior quarter.
• The five-year high for Construction in Progress was $1.2 billion in Q4 2022, with the low at $907.0 million in Q4 2019.
• Average Construction in Progress over 5 years is $995.0 million, with a median of $953.0 million recorded in 2018.
• The sharpest annual moves came in 2019 and 2022: Construction in Progress slipped 4.83% in 2019, then gained 22.9% in 2022.
• Over 5 years, Construction in Progress stood at $953.0 million in 2018, then dropped by 4.83% to $907.0 million in 2019, then climbed by 0.88% to $915.0 million in 2020, then rose by 7.87% to $987.0 million in 2021, then increased by 22.9% to $1.2 billion in 2022.
• The last three Construction in Progress figures came in at $1.2 billion (Q4 2022), $987.0 million (Q4 2021), and $915.0 million (Q4 2020), per Business Quant data.